AnalystBook Research · Company Intelligence

AVENUE THERAPEUTICS, INC.

ATXIOTCCIK 0001644963

Built from AVENUE THERAPEUTICS, INC.'s own SEC filings · updates as new filings land · every figure links to its source

The read at a glance

Computed from the FY2021 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -56.90 distress zone — historically elevated failure riskWatch

Latest filings

  • 10-Q · Quarterly report2026-05-08
  • 10-K · Annual report2026-03-30
  • 8-K · Company announcement2026-02-23
  • 8-K · Company announcement2025-12-31
  • DEF 14A · Annual proxy (pay & governance)2025-12-05
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, every figure source-linked🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask anything about AVENUE THERAPEUTICS, INC., every answer cited🔒
  • The Intelligence Brief — added when AVENUE THERAPEUTICS, INC.'s brief passes our SEC-figure check🔒

Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.